Drug firm Pfizer on Thursday reported a standalone net profit of Rs 131.94 crore for the third quarter ended December 2018.
It had reported a net profit of Rs 87.24 crore in the October-December quarter of the last financial year, Pfizer said in a BSE filing.
Pfizer's total income was Rs 578.14 crore during the quarter under review. It was Rs 488.62 crore in the corresponding quarter a year ago.
Meanwhile, the company said that its result was not comparable as sales for the nine months ended December 2017 include excise duty up to June 30, 2017.
Pfizer's total expenses stood at Rs 377.52 crore.
Shares of Pfizer Ltd on Thursday settled at Rs 2,681.50 on BSE, up 0.62 per cent from their previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app